Lauren Marangell, M.D. to Join Lilly; Internationally Recognized Expert in Depression Joins as Distinguished Lil...( INDIANAPOLIS Sept. 21 /- Eli Lill...),Health

INDIANAPOLIS, Sept. 21 /PRNewswire-FirstCall/ -- Eli Lilly and Company (NYSE: LLY) today announced that Lauren Marangell, M.D., will join Lilly in November 2007, as a Distinguished Lilly Scholar focusing on depression and related disorders.

"We are delighted to recruit someone with Dr. Marangell's stature and depth of experience to join Lilly," said Jack Harris, M.D., vice president, U.S. medical division. "Lauren brings a national and international reputation in depression and other mood disorders. This experience will allow her to play a key scientific leadership role in our relationships with the U.S. healthcare community and the broader clinical and scientific community, providing quality information regarding Lilly products and research."

Marangell joins Lilly from Baylor College of Medicine where she is Brown Foundation Chair in psychopharmacology of mood disorders, professor of psychiatry with tenure and director of mood disorders research. At Baylor, she developed a state-of-the-art mood disorders research program recognized as one of the most successful in the country. She has held numerous national and international leadership positions and is a scientific reviewer for most major journals in the field. In addition to her success in research, Marangell is well known as a prominent clinician and educator. Among many awards of note, she is a recipient of the "Exemplary Psychiatrist Award" from the National Alliance for the Mentally Ill, and is listed in "Who's Who Among American Educators." She is first author of the "Concise Guide to Psychopharmacology", with coauthor James Martinez, M.D., now also with Lilly.

"I am very excited that Lauren chose to join Lilly," said John Hayes, M.D., vice pre
'/>"/>